Shandong New Time Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is CARFILZOMIB, with a corresponding US DMF Number 38290.
Remarkably, this DMF maintains an Active status since its submission on May 16, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 05, 2023, and payment made on May 15, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II